A new conducted in both mice and a small group of patients with advanced cancers has shown that so-called ‘cold’ tumors that are nearly devoid of immune cells—and therefore unresponsive to immunotherapy—can be turned ‘hot’ with extremely low doses of radiation and the rational use of existing therapies.